Search

» » Sanofi may win U.S. approval of $3 billion eczema drug by March

Sanofi may win U.S. approval of $3 billion eczema drug by March

(Reuters) - French drugmaker Sanofi  and its U.S. partner Regeneron Pharmaceuticals could win U.S. approval for their keenly awaited new eczema drug dupilumab, seen by analysts as a potential $3 billion-a-year seller, by next March.

Sanofi may win U.S. approval of $3 billion eczema drug by March
Read More


Bagikan Berita Ini

Related Posts :

0 Response to "Sanofi may win U.S. approval of $3 billion eczema drug by March"

Posting Komentar

Langganan: Posting Komentar (Atom)
Diberdayakan oleh Blogger.